The Use of Reporting Guidelines in Rheumatology: A Cross-Sectional Study of Over 850 Manuscripts Published in 5 Major Rheumatology Journals
Open Access
- 15 January 2023
- journal article
- research article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 50 (7) , 939-943
Abstract
Objective: To assess whether 16 of the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network–related reporting guidelines were used in rheumatology publications.Methods: This was a cross-sectional study of research articles published in 5 high-performance rheumatology-focused journals in 2019. All articles were (1) manually reviewed to assess whether the use of a reporting guideline could be advisable, and (2) searched for the names and acronyms (eg, CONSORT [Consolidated Standards of Reporting Trials], STROBE [Strengthening the Reporting of Observational Studies in Epidemiology]) of 16 reporting guidelines. To calculate the “advisable use rate,” the number of articles for which a guideline was used was divided by the number of articles for which the guideline was advised. Descriptive statistics were used.Results: We reviewed 895 manuscripts across the 5 journals. The use of a guideline was deemed advisable for 693 (77%) articles. Reporting guidelines were used in 50 articles, representing 5.6% of total articles and 7.2% (95% CI 5-9) of articles for which guidelines were advised. The advisable use rate boundaries within which a guideline was applied by the journals were 0.03 to 0.10 for any guideline, 0 to 0.26 for CONSORT, 0.01 to 0.07 for STROBE, 0 to 0.8 for Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), and 0 to 0.14 for Animal Research: Reporting of In Vivo Experiments (ARRIVE). No identifiable trends in the variables studied were observed across the 5 journals.Conclusion: The limited use of reporting guidelines appears counterintuitive, considering that guidelines are promoted by journals and are intended to help authors report relevant information. Whether this finding is attributable to issues with the diffusion, awareness, acceptance, or perceived usefulness of the guidelines remains to be clarified.Keywords
This publication has 19 references indexed in Scilit:
- Trial registration and adherence to reporting guidelines in cardiovascular journalsHeart, 2017
- A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomesTrials, 2016
- Quality of Reporting and Study Design of CKD Cohort Studies Assessing Mortality in the Elderly Before and After STROBE: A Systematic ReviewPLOS ONE, 2016
- Assessment of the Quality of Reporting of Randomised Controlled Trials in Otorhinolaryngologic Literature – Adherence to the CONSORT StatementPLOS ONE, 2015
- The explicit mentioning of reporting guidelines in urogynecology journals in 2013: A bibliometric studyNeurourology and Urodynamics, 2015
- What is the impact of reporting guidelines on Public Health journals in Europe? The case of STROBE, CONSORT and PRISMAJournal of Public Health, 2014
- Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewaSystematic Reviews, 2012
- Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysisBMJ, 2012
- Uses and misuses of the STROBE statement: bibliographic studyBMJ Open, 2011
- A Critical Assessment of the Quality of Reporting of Randomized, Controlled Trials in the Urology LiteratureJournal of Urology, 2007